Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OGN Organon & Co

休市中 10-23 16:00:00 EDT

13.75

+0.00

0.00%

盘后13.74

-0.01-0.07%

19:30 EDT

最高13.76	最低13.74	成交量105.40万
今开13.74	昨收13.75	日振幅0.15%
总市值36.11亿	流通市值33.41亿	总股本2.63亿
成交额1,450万	换手率0.43%	流通股本2.43亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OGN","market":"US","secType":"STK","nameCN":"Organon & Co","latestPrice":13.75,"timestamp":1792785600000,"preClose":13.75,"halted":0,"volume":1054002,"hourTrading":{"tag":"盘后","latestPrice":13.7407,"preClose":13.75,"latestTime":"19:30 EDT","volume":16468,"amount":226416.684,"timestamp":1792798204700,"change":-0.0093,"changeRate":-0.000676,"amplitude":0.000676},"delay":0,"changeRate":0,"floatShares":243000000,"shares":262600862,"eps":0.792897,"marketStatus":"休市中","change":0,"latestTime":"10-23 16:00:00 EDT","open":13.74,"high":13.76,"low":13.74,"amount":14496459.981462,"amplitude":0.001455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.792897,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":13.75,"dividendRate":0.005818,"preHourTrading":{"tag":"盘前","latestPrice":13.755,"preClose":13.75,"latestTime":"08:05 EDT","volume":93,"amount":1278.760044,"timestamp":1792757117958,"change":0.005,"changeRate":0.000364,"amplitude":0.000364},"postHourTrading":{"tag":"盘后","latestPrice":13.7407,"preClose":13.75,"latestTime":"19:30 EDT","volume":16468,"amount":226416.684,"timestamp":1792798204700,"change":-0.0093,"changeRate":-0.000676,"amplitude":0.000676},"volumeRatio":0.3886515439638688,"impliedVol":0.0035,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/OGN","defaultTab":"news","newsList":[{"id":"1182027615","title":"Organon宣布美国FDA受理Miudella®无激素宫内节育器补充新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1182027615","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182027615?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:31","pubTimestamp":1789385477,"startTime":"0","endTime":"0","summary":"Organon & Co今日宣布，美国食品药品监督管理局已正式受理其针对Miudella——一款无激素宫内节育器——提交的补充新药申请并进入审查流程。Miudella作为一种非激素类的宫内节育系统，旨在为女性提供长效、可逆的避孕选择，同时规避激素相关副作用。Organon公司表示，若获批，Miudella将为那些寻求非激素避孕方案的女性带来新的治疗选项，进一步丰富公司在女性健康领域的产品组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065171311.SGD","OGN","LU2065170008.USD","BK4007","FXH","LU2065169927.USD","BK4585","BK4559","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173872690","title":"Organon & Co 坚信诉状指控及未决禁令动议中的主张均缺乏依据","url":"https://stock-news.laohu8.com/highlight/detail?id=1173872690","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173872690?lang=zh_cn&edition=full","pubTime":"2026-07-18 04:11","pubTimestamp":1784319071,"startTime":"0","endTime":"0","summary":"Organon & Co 公司明确表示，其认为当前诉讼中的各项指控、申诉内容以及相关未决禁令动议所提出的主张，均缺乏事实与法律依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","BK4588","BK4559","LU2065171311.SGD","OGN","BK4007","FXH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171337952","title":"针对Organon董事会及太阳制药美国子公司提起的诉讼已提交SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1171337952","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171337952?lang=zh_cn&edition=full","pubTime":"2026-07-18 04:10","pubTimestamp":1784319011,"startTime":"0","endTime":"0","summary":"一份针对Organon & Co董事会、太阳制药美国公司以及太阳制药美洲公司的诉讼，已于2026年7月6日向美国证券交易委员会提交了相关文件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BK4559","OGN","FXH","BK4588","BK4007","LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177334937","title":"Organon 完成授权协议，获得 Sebela Pharmaceuticals 无激素宫内节育器 Miudella®","url":"https://stock-news.laohu8.com/highlight/detail?id=1177334937","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177334937?lang=zh_cn&edition=full","pubTime":"2026-06-22 19:30","pubTimestamp":1782127840,"startTime":"0","endTime":"0","summary":"Organon & Co 已达成并完成一项授权协议，获得 Sebela Pharmaceuticals 旗下无激素宫内节育器 Miudella® 的相关权益。此举旨在拓展 Organon 在女性健康领域的创新产品组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2065171311.SGD","BK4559","BK4588","OGN","LU2065171402.SGD","LU2065170008.USD","LU2065169927.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100440185","title":"Organon与三星Bioepis扩大协议，在加拿大商业化生物类似药Pyzchiva®（乌司奴单抗）","url":"https://stock-news.laohu8.com/highlight/detail?id=1100440185","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100440185?lang=zh_cn&edition=full","pubTime":"2026-06-18 18:00","pubTimestamp":1781776844,"startTime":"0","endTime":"0","summary":"Organon与三星Bioepis已就扩大合作协议达成一致，旨在加拿大市场共同商业化生物类似药Pyzchiva。该药物参照原研药Stelara开发。此次协议扩展标志着双方在生物类似药领域合作的深化，旨在为加拿大患者提供更多治疗选择。此举不仅强化了Organon在生物类似药领域的布局，也体现了三星Bioepis在生物制剂开发方面的持续投入。随着协议范围的扩大，双方期待能更有效地满足加拿大医疗市场的需求，并为医疗系统带来潜在的成本效益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN","BK4007","LU2065171311.SGD","LU2065169927.USD","BK4559","LU2065171402.SGD","BK4585","LU2065170008.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198057523","title":"欧盟委员会批准复宏汉霖与Organon的Poherdy®（帕妥珠单抗） 成为欧洲首个获准的Perjeta（帕妥珠单抗）生物类似药","url":"https://stock-news.laohu8.com/highlight/detail?id=1198057523","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198057523?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:31","pubTimestamp":1777455074,"startTime":"0","endTime":"0","summary":"欧盟委员会正式批准了复宏汉霖与Organon公司联合开发的Poherdy®（帕妥珠单抗），该药物成为欧洲地区首个获得上市许可的Perjeta（帕妥珠单抗）生物类似药。这一批准标志着两家公司在生物制药领域取得重要突破，将为欧洲市场提供更多治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","OGN","BK4007","HK0000306701.USD","BK4585","BK4588","LU2065170008.USD","02696","HK0000320264.USD","LU2065171402.SGD","LU2065171311.SGD","HK0000306685.HKD","BK1161","BK4559","HK0000165453.HKD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117334061","title":"特定情况下交易终止 Organon & Co将向太阳制药美国控股支付1.2亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1117334061","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117334061?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:12","pubTimestamp":1777284733,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会的文件披露，若在特定情形下交易协议被终止，Organon & Co将需要向Sun Pharmaceutical Holdings USA支付高达1.2亿美元的终止费用。\n该条款明确了交易双方在意外情况下的责任归属，展现出合作协议中对风险管控的重视。这笔巨额解约费的设定，既体现了交易价值的重要性，也为可能出现的变数提供了明确的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065171311.SGD","OGN","LU2065170008.USD","BK4007","LU2065169927.USD","BK4585","BK4559","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135181552","title":"异动解读 | 获太阳制药溢价收购，Organon盘前大涨14.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135181552","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135181552?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:06","pubTimestamp":1777277217,"startTime":"0","endTime":"0","summary":"消息面上，此次股价异动的直接原因是印度制药巨头太阳制药工业公司宣布将以全现金交易方式收购Organon。根据协议，太阳制药将以每股14.00美元的现金价格收购Organon的所有流通股，这一价格较Organon前一交易日的收盘价溢价超过24%。市场分析认为，这笔高溢价的收购要约显著提升了Organon的股东价值，是推动其股价在盘前交易时段强劲上涨的核心动力。收购预计将扩大太阳制药的国际业务版图，并使其获得Organon在女性健康、生物类似药及成熟药物领域的产品组合。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182099951","title":"异动解读 | 获太阳制药溢价收购，Organon夜盘大涨15.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182099951","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182099951?lang=zh_cn&edition=full","pubTime":"2026-04-27 15:34","pubTimestamp":1777275295,"startTime":"0","endTime":"0","summary":"根据协议，太阳制药将以每股14.00美元的价格收购Organon所有流通股，这一价格较Organon前一交易日的收盘价溢价超过24%。收购预计将扩大太阳制药的国际版图，并使其获得Organon在女性健康、生物类似药及成熟药物领域的产品组合，覆盖全球约140个国家。市场普遍认为，这笔高溢价的收购要约是推动Organon股价在夜盘大幅走高的核心动力。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102141116","title":"印度太阳药业董事长：与Organon合作将助其进军尚未涉足的市场区域","url":"https://stock-news.laohu8.com/highlight/detail?id=1102141116","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102141116?lang=zh_cn&edition=full","pubTime":"2026-04-27 13:41","pubTimestamp":1777268471,"startTime":"0","endTime":"0","summary":"印度太阳药业董事长表示，与Organon & Co达成的合作协议将为公司提供宝贵机遇，使其能够在目前尚未开展业务的全球市场推出产品。这一战略合作将有效拓展太阳药业的地理覆盖范围，开辟新的增长空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065170008.USD","LU2065171311.SGD","BK4007","BK4559","OGN","LU2065169927.USD","LU2065171402.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630355828","title":"医药行业“新巨头”诞生！太阳制药斥资117.5亿美元收购Organon","url":"https://stock-news.laohu8.com/highlight/detail?id=2630355828","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630355828?lang=zh_cn&edition=full","pubTime":"2026-04-27 10:58","pubTimestamp":1777258724,"startTime":"0","endTime":"0","summary":"根据协议，Organon 的股东将获得每股 14 美元的现金。该交易已获得两家公司董事会的批准，在获得监管机构批准和 Organon 股东批准的前提下，预计将于 2027 年初完成。截至 12 月 31 日的财年，Organon 报告的收入为 62 亿美元，调整后的息税折旧摊销前利润为 19 亿美元。对于投资者而言，这笔交易的成功与否，可能取决于太阳制药整合 Organon 产品组合、管理杠杆以及从其扩张后的全球平台中产生增长的能力。","market":"sh","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434189.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"医药行业“新巨头”诞生！太阳制药斥资117.5亿美元收购Organon","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2065169927.USD","BK4559","BK1574","LU2065171402.SGD","OGN","BK4588","BK1191","LU2065171311.SGD","BK4585","LU2065170008.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120142490","title":"美股夜盘 | 闪迪涨近3%，英特尔、台积电涨超2%；Organon续涨21%，上一交易日暴涨近31%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120142490","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120142490?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:14","pubTimestamp":1777248893,"startTime":"0","endTime":"0","summary":"4月27日，美股夜盘时段，加密货币股普涨，$Strategy(MSTR)$、$BitMine Immersion Technologies Inc.(BMNR)$涨超2%，$、$Coinbase Global, Inc.(COIN)$、Cleanspark、$Robinhood(HOOD)$涨超1%。$英特尔(INTC)$续涨1%，上一交易日涨超23%；$台积电(TSM)$续涨2%，上一交易日涨超5%。Organon续涨21%，上一交易日暴涨近31%。有报道称印度Sun Pharmaceutical Industries计划收购该公司。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","LU2360106780.USD","MSOO","LU2491050071.SGD","LU2663582299.SGD","LU0321505439.SGD","LU0056508442.USD","MSTK","LU1868838027.USD","LU0289960550.SGD","LU0861579265.USD","LU1989772840.SGD","LU2023250504.SGD","LU0359201612.USD","BK4503","TSMZ","LU0878005551.USD","LU2491050154.USD","LU2237443382.USD","MSTU","LU1282649067.USD","LU1934455863.HKD","IE000M9KFDE8.USD","LU1323610961.USD","SG9999004220.SGD","LU0488056044.USD","INTC","LU0572939691.SGD","TSMX","BK4554","LU0198837287.USD","BK4588","IE00BQXX3F31.USD","LU0642271901.SGD","LU2054465674.USD","LU2491049909.HKD","MSDD","OGN","LU2750360641.GBP","BK4575","LU2106854487.HKD","MTYY","LU0321505868.SGD","LU2506951792.HKD","BK4534","LU2458330243.SGD","LU0143863784.USD","LU0353189680.USD","LU2247934214.USD","MSTR","IE00BQXX3D17.EUR","LU0889566641.SGD","LU2298321311.HKD","LU2023251221.USD","LU0965509010.AUD","LU0541501648.USD","LU1037948541.HKD","BK4527","LU2148611432.USD","LU2237443622.USD","LU0965508806.USD","TSMU","LU0823414478.USD","LU2089284900.SGD","LU2211815571.USD","LU1917777945.USD","MSST","LU0238689110.USD","IE00BHPRN162.USD","LU1868837565.USD","IE00B5TLWC47.USD","LU2271345857.HKD","LU0124676726.USD","LU2543165471.USD","LU0109392836.USD","LU1316542783.SGD","LU1989772923.USD","MSTW","SGXZ51526630.SGD","IE00BQXX3C00.GBP","LU2089985449.USD","LU1989764748.USD","BK4605","LU2125154778.USD","BK4612","IE00BFXG0V08.USD","IE0004086264.USD","LU0097036916.USD","LU0965509283.SGD","IE00BD6J9T35.USD","BK4512","IE00BKPKM429.USD","LU0345770993.USD","BK4515","LU0965509101.SGD","LU2249611893.SGD","MST","LU0143863198.USD","BK4504","BK4591","BK4579","LU1803068979.SGD","LU0348723411.USD","LU1023057109.AUD","LU2063271972.USD","LU1852331112.SGD","LU0345770308.USD","LU2089283258.USD","LU2211814178.USD","LU2471134879.HKD","LU0316494557.USD","LU0792757196.USD","BK4141","BK4532","LU0082616367.USD","LU2471134523.USD","LU0889565833.HKD","BK4548","LU0689626769.HKD","LU0323591593.USD","LU2458330169.SGD","LU0158827781.USD","LU1508157978.USD","LU2471134952.CNY","LU1712237335.SGD","LU0878004406.USD","LU0081259029.USD","IE00BZ199S13.USD","LU1868837722.USD","LU2360108059.USD","LU2750360997.AUD","SG9999000418.SGD","BK4535","LU2028103732.USD","BK4529","IE00B3M56506.USD","LU1211504680.USD","LU0541502299.USD","MSTP","BK4602","LU0359202008.SGD","LU0264606111.USD","LU1623119135.USD","MSTZ","TSMY","LU2125154935.USD","LU0384037296.USD","LU2931357623.SGD","TSM","LU1989764664.SGD","BK4585","LU0094547139.USD","BK4581","LU0353189763.USD","LU1267930813.SGD","LU1974910355.USD","SMST","SGXZ81514606.USD","LU0823421333.USD","LU2360032135.SGD","LU0719512351.SGD","LU2092937221.SGD","IE0004445239.USD","MSTY","WNTR","LU1282649810.SGD","IMST","LU2111349929.HKD","LU0359201885.HKD","IE0004091025.USD","IE00BYQQ9H92.USD","LU2237443549.SGD","LU0823421416.USD","LU2041044095.USD","BK4550","LU0572940350.SGD","LU2237443978.SGD","LU1934455277.USD","LU2133065610.SGD","LU2250418816.HKD","LU0158827948.USD","LU0882747503.HKD","LU0175139822.USD","LU1934455194.USD","LU0274383776.USD","LU1037948897.HKD","LU2471134796.USD","LU2860962120.EUR","BK4533","SGXZ99366536.SGD","LU2087625088.SGD","LU2294711713.HKD","LU2357125470.USD","MSTX","BK4505","BK4526","MSII","LU0823414551.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514017881","title":"Organon & Co.盘中异动 急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514017881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514017881?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:29","pubTimestamp":1740504592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时29分，Organon & Co.股票出现波动，股价快速上涨5.11%。截至发稿，该股报15.85美元/股，成交量154.74万股，换手率0.60%，振幅4.58%。Organon & Co.股票所在的制药行业中，整体涨幅为1.33%。Organon & Co.公司简介：Organon & Co 是一家以科学为基础的全球制药公司，通过妇女保健，生物仿制药和知名品牌的处方治疗组合，开发和提供健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012952a253aec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012952a253aec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","BK4585","LU2065169927.USD","LU2065171402.SGD","LU2065170008.USD","BK4007","OGN","BK4588","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511137596","title":"Organon & Co.盘中异动 股价大跌5.06%报15.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511137596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511137596?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:58","pubTimestamp":1739555939,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时58分，Organon & Co.股票出现异动，股价大幅跳水5.06%。截至发稿，该股报15.50美元/股，成交量153.16万股，换手率0.59%，振幅6.04%。Organon & Co.股票所在的制药行业中，整体跌幅为1.14%。Organon & Co.公司简介：Organon & Co 是一家以科学为基础的全球制药公司，通过妇女保健，生物仿制药和知名品牌的处方治疗组合，开发和提供健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015859a2462d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015859a2462d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4559","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","BK4588","OGN","LU2065169927.USD","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138052935","title":"异动解读 | Organon &Co. 2024年第四季度财报喜人 盘中股价大涨10.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138052935","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138052935?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:14","pubTimestamp":1739459668,"startTime":"0","endTime":"0","summary":"Organon & Co. 周四盘中股价出现大涨10.1%的行情,给投资者带来可观回报。引发该公司股价上涨的主要原因在于,Organon近期公布了2024年第四季度财报。具体来看,Organon 2024年第四季度每股收益较去年同期增长2.27%,至0.90美元,较市场预期数据更为亮眼。销售额方面,公司季度收入录得15.9亿美元,虽同比微降0.38%,但符合分析师平均预期水平。该公司每股收益超预期的出色表现,使得投资者对其前景信心倍增,从而推动当日股价出现双位数涨幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525722","title":"Organon & Co.盘中异动 早盘股价大涨8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511525722?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:30","pubTimestamp":1739457023,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时30分，Organon & Co.股票出现异动，股价大幅上涨8.98%。Organon & Co.股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，Organon & Co.、Aytu Biopharma, Inc.、Biofrontera Inc.涨幅较大，大自然药业、Quantum Biopharma Ltd.、Cbdmd, Inc.较为活跃，换手率分别为6.93%、1.38%、1.01%，振幅较大的相关个股有Aquestive Therapeutics, Inc.、吉利德科学、Phibro Animal Health Corporation，振幅分别为1.47%、0.77%、0.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223024a244aabf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223024a244aabf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU2065171311.SGD","BK4559","BK4588","OGN","LU2065171402.SGD","LU2065170008.USD","LU2065169927.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176929249","title":"Organon 2024年第四季度调整后每股收益$0.90超出预期$0.87，销售额$15.9亿符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1176929249","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176929249?lang=zh_cn&edition=full","pubTime":"2025-02-13 20:43","pubTimestamp":1739450584,"startTime":"0","endTime":"0","summary":"Organon 报告季度每股收益为$0.90，超出分析师一致预期的$0.87，超出比例为3.45%。这较去年同期的每股收益$0.88增加了2.27%。这较去年同期的销售额$16.0亿减少了0.38%。以上内容来自Benzinga Earnings专栏，原文如下：Organon  reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.87 by 3.45 percent. This is a 2.27 percent increase over earnings of $0.88 per share from the same period last year.  The company reported quarterly sales of $1.59 billion which met the analyst consensus estimate.  This is a 0.38 percent decrease over sales of $1.6","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114333700","title":"Organon预计2025年销售额为61.25亿美元至63.25亿美元，低于预期的64.71亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114333700","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114333700?lang=zh_cn&edition=full","pubTime":"2025-02-13 20:42","pubTimestamp":1739450542,"startTime":"0","endTime":"0","summary":"组织公司未提供基于GAAP的财务预测，因为公司无法在合理确定性和不需过多努力的情况下，预测法律诉讼最终结果、异常收益和损失、产生GAAP税项影响事项及与收购相关的费用。这些项目是不确定的，取决于各种因素，可能对根据GAAP计算的Organon结果有重大影响。2024全年实际业绩和2025年财务指引如下，除收入外，这些数据基于非GAAP标准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Organon预计2025年销售额为61.25亿美元至63.25亿美元，低于预期的64.71亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486036835","title":"Organon & Co.盘中异动 早盘大幅拉升5.04%报16.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486036835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486036835?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:26","pubTimestamp":1732548373,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时26分，Organon & Co.股票出现波动，股价快速上涨5.04%。截至发稿，该股报16.05美元/股，成交量49.3142万股，换手率0.19%，振幅3.57%。Organon & Co.股票所在的制药行业中，整体涨幅为0.19%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232613abde1550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232613abde1550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","BK4559","OGN","BK4588","BK4007","LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482485713","title":"Organon & Co.2024财年第三财季实现净利润3.59亿美元，同比增加518.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482485713?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081631,"startTime":"0","endTime":"0","summary":"11月9日，Organon & Co.公布财报，公告显示公司2024财年第三财季净利润为3.59亿美元，同比增加518.97%；其中营业收入为15.82亿美元，同比增加4.15%，每股基本收益为1.39美元。从资产负债表来看，Organon & Co.总负债122.59亿美元，其中短期债务10.00百万美元，资产负债比为1.05，流动比率为1.71。机构评级：截至2024年11月9日，当前有8家机构对Organon & Co.目标价做出预测，其中目标均价为22.50美元，其中最低目标价为17.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000229abae6f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000229abae6f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.organon.com","stockEarnings":[{"period":"1week","weight":-0.0007},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.017},{"period":"6month","weight":0.2211},{"period":"1year","weight":0.5193},{"period":"ytd","weight":0.9177}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Organon & Co.是一家于2020年3月11日在特拉华州注册成立的公司。该公司是一家全球性的医疗保健公司，其使命是提供有影响力的药物和解决方案，让每一天都更健康。该公司在女性健康和普通药物领域拥有70多种产品组合，其中包括生物仿制药，专注于满足对女性有独特、不成比例或不同影响的健康需求，同时在140多个国家和地区扩大基本治疗的可及性。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.103066},{"month":2,"riseRate":0.4,"avgChangeRate":-0.031967},{"month":3,"riseRate":0.2,"avgChangeRate":-0.040746},{"month":4,"riseRate":0.4,"avgChangeRate":0.208608},{"month":5,"riseRate":0.6,"avgChangeRate":-0.034517},{"month":6,"riseRate":0.6,"avgChangeRate":-0.000465},{"month":7,"riseRate":0.666667,"avgChangeRate":0.002268},{"month":8,"riseRate":0.5,"avgChangeRate":0.012631},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.072736},{"month":10,"riseRate":0.5,"avgChangeRate":-0.048516},{"month":11,"riseRate":0.2,"avgChangeRate":-0.091617},{"month":12,"riseRate":0.6,"avgChangeRate":0.051819}],"exchange":"NYSE","name":"Organon & Co","nameEN":"Organon & Co"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Organon & Co,OGN,Organon & Co股票,Organon & Co股票老虎,Organon & Co股票老虎国际,Organon & Co行情,Organon & Co股票行情,Organon & Co股价,Organon & Co股市,Organon & Co股票价格,Organon & Co股票交易,Organon & Co股票购买,Organon & Co股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}